approval
saveNUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: COLLEGIUM PHARM INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalTAPENTADOL HYDROCHLORIDE — FDA approvalFeb 10, 2026 · 236d ago
- approvalTAPENTADOL HYDROCHLORIDE — FDA approvalJan 26, 2026 · 251d ago
- approvalNUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approvalDec 22, 2025 · 286d ago
- approvalNUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approvalDec 22, 2025 · 286d ago
- approvalNUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approvalOct 31, 2024 · 703d ago
- approvalNUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approvalOct 31, 2024 · 703d ago
- approvalNUCYNTA ER (TAPENTADOL HYDROCHLORIDE) — FDA approvalOct 31, 2024 · 703d ago
- approvalNUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approvalJun 14, 2024 · 842d ago
same company · ±60 days · 6
- approvaltapentadol hydrochloride ER: NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approvalDec 22, 2025
- approvaltapentadol hydrochloride ER: NUCYNTA (TAPENTADOL HYDROCHLORIDE) — FDA approvalDec 22, 2025
- approvaloxycodone ER: XTAMPZA ER (OXYCODONE) — FDA approvalDec 22, 2025
- approvalMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalJan 15, 2026
- approvalMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalJan 15, 2026
- approvalMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalJan 15, 2026
comments(0)
5-min edit window · permanent after that